As our network of nurses continues to grow, we are facilitating more decentralised trials and carrying out an ever-increasing number of clinical trial visits to patients in their own homes.

mdgroup is proud to be a founding member of the Decentralised Clinical Trials and Research Alliance (DTRA).

In this in-depth guide, we look at all aspects of patient engagement across the entire clinical trial journey, and why it’s important in ensuring diversity amongst participants and looking after patients’ mental wellbeing.

Effective communication is essential for patient engagement and retention during a clinical trial – especially as more trials are moving to virtual or decentralised models.

There’s no doubt of the seismic impact COVID-19 has had on clinical trials. As a result of safety measures, the industry has had no choice but to start moving towards an approach which minimises or eliminates the need for travel and contact. As a result, more and more trials are being held virtually, and completely decentralised trials are increasingly more common.

The #NoGoingBack pledge is a statement from organisations across the world to continue forging forward. It’s a united front, and shows the importance of clinical leaders coming together to continue the momentum we’ve created in improving clinical trial conduct around the world.